drugset / Trial / NCT03463512

Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea

NCT03463512 ↗

Phase 3 Completed 124 enrolled Abbott
RandomizedParallel-groupOpen-labelTreatment

Summary

Multicenter, open-label, controlled, randomized clinical study to evaluate the efficacy and safety of Racecadotril in infants, children and adolescents with acute diarrhea

Timeline

Start
2018-03-29
Primary completion
2018-09-10
Completion
2018-09-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Racecadotril Small molecule — —

Indications